DeepMed Research

ABBVIE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2013-01-01

Employees: -

Market Cap: $346B

Website: http://www.abbvie.com

Clinical Trials

An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

Phase 1

Completed

Conditions: Advanced Solid Tumors

Interventions: Drug: ABT-806

First Posted Date: 2011-08-01

Last Posted Date: 2017-01-27

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 14

Registration Number: NCT01406119

Locations: 🇺🇸
Site Reference ID/Investigator# 58883, Baltimore, Maryland, United States
🇺🇸
Site Reference ID/Investigator# 58882, Boston, Massachusetts, United States
🇦🇺
Site Reference ID/Investigator# 60619, Heidelberg, Australia

and more 1 locations

An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

Phase 1

Completed

Conditions: Folliculogenesis

Interventions: Drug: elagolix

First Posted Date: 2011-07-27

Last Posted Date: 2013-01-08

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 216

Registration Number: NCT01403038

Locations: 🇺🇸
Site Reference ID/Investigator# 50805, Colorado Springs, Colorado, United States
🇺🇸
Site Reference ID/Investigator# 51270, Colorado Springs, Colorado, United States
🇺🇸
Site Reference ID/Investigator# 50884, Denver, Colorado, United States

and more 19 locations

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Completed

Conditions: Moderate to Severe Plaque Psoriasis

First Posted Date: 2011-07-25

Last Posted Date: 2017-10-04

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 246

Registration Number: NCT01401452

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

Completed

Conditions: Secondary Hyperparathyroidism

First Posted Date: 2011-07-25

Last Posted Date: 2014-03-03

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 86

Registration Number: NCT01401478

Locations: 🇷🇺
Site Reference ID/Investigator# 58347, Chelyabinsk, Russian Federation
🇷🇺
Site Reference ID/Investigator# 57348, Almetyevsk, Russian Federation
🇷🇺
Site Reference ID/Investigator# 67404, Iakutsk, Russian Federation

and more 10 locations

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Phase 2

Completed

Conditions: Chronic Kidney Disease
Diabetic Nephropathy

Interventions: Drug: Placebo
Drug: Atrasentan

First Posted Date: 2011-07-22

Last Posted Date: 2013-10-25

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 48

Registration Number: NCT01399580

Locations: 🇺🇸
Site Reference ID/Investigator# 56927, Azusa, California, United States
🇺🇸
Site Reference ID/Investigator# 70173, Los Angeles, California, United States
🇺🇸
Site Reference ID/Investigator# 55543, Flushing, New York, United States

and more 25 locations

A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2011-07-06

Last Posted Date: 2014-05-05

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 71

Registration Number: NCT01387789

Locations: 🇲🇾
Site Reference ID/Investigator# 36098, Batu Caves, Malaysia
🇲🇾
Site Reference ID/Investigator# 57916, Kuala Lumpur, Malaysia
🇲🇾
Site Reference ID/Investigator# 57924, Kuching, Malaysia

and more 10 locations

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Completed

Conditions: Psoriasis

Interventions: Biological: Adalimumab

First Posted Date: 2011-07-06

Last Posted Date: 2019-12-05

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 662

Registration Number: NCT01387815

Locations: 🇨🇦
Jason Ronald Sneath Medical Co /ID# 138026, Brandon, Manitoba, Canada
🇨🇦
Winnipeg Clinic, Manitoba, CA /ID# 56865, Winnipeg, Manitoba, Canada
🇨🇦
Dr. Loukia-Maria Mitsos /ID# 124156, Pierrefonds, Quebec, Canada

and more 33 locations

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Completed

Conditions: Ankylosing Spondylitis

First Posted Date: 2011-07-06

Last Posted Date: 2020-12-09

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 722

Registration Number: NCT01387802

Locations: 🇨🇦
Dr. Barbara T. Blumenauer Inc. /ID# 55226, Kamloops, British Columbia, Canada
🇨🇦
Ecker, Fredericton, CA /ID# 54748, Fredericton, New Brunswick, Canada
🇨🇦
Pont, Cranbrook, BC, CA /ID# 55242, Cranbrook, British Columbia, Canada

and more 53 locations

Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study

Completed

Conditions: Prostate Cancer

First Posted Date: 2011-07-01

Last Posted Date: 2018-12-13

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 552

Registration Number: NCT01386684

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Completed

Conditions: Human Immunodeficiency Virus Infection

First Posted Date: 2011-06-28

Last Posted Date: 2013-05-06

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 97

Registration Number: NCT01383005

Locations: 🇪🇸
Site Ref # / Investigator 52362, Cartagena, Spain
🇪🇸
Site Ref # / Investigator 52274, A Coruna, Spain
🇪🇸
Site Ref # / Investigator 52273, Ferrol (A Coruna), Spain

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy